| Literature DB >> 29697279 |
Weimin Kong1,2,3, Simon F Lacey1,2,3, Jan Joseph Melenhorst1,2,3, Joseph A Fraietta1,2,3.
Abstract
Keywords: CAR; CTL019; Kymriah; T cell; Tisagenlecleucel; biomarker; cancer; cell therapy; immunotherapy; translational medicine
Mesh:
Substances:
Year: 2018 PMID: 29697279 DOI: 10.2217/bmm-2018-0054
Source DB: PubMed Journal: Biomark Med ISSN: 1752-0363 Impact factor: 2.851